188 related articles for article (PubMed ID: 21821041)
1. The TβR-I pre-helix extension is structurally ordered in the unbound form and its flanking prolines are essential for binding.
Zuniga JE; Ilangovan U; Mahlawat P; Hinck CS; Huang T; Groppe JC; McEwen DG; Hinck AP
J Mol Biol; 2011 Sep; 412(4):601-18. PubMed ID: 21821041
[TBL] [Abstract][Full Text] [Related]
2. TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.
Baardsnes J; Hinck CS; Hinck AP; O'Connor-McCourt MD
Biochemistry; 2009 Mar; 48(10):2146-55. PubMed ID: 19161338
[TBL] [Abstract][Full Text] [Related]
3. Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.
Radaev S; Zou Z; Huang T; Lafer EM; Hinck AP; Sun PD
J Biol Chem; 2010 May; 285(19):14806-14. PubMed ID: 20207738
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12.
Huse M; Chen YG; Massagué J; Kuriyan J
Cell; 1999 Feb; 96(3):425-36. PubMed ID: 10025408
[TBL] [Abstract][Full Text] [Related]
7. Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells.
Chen CL; Huang SS; Huang JS
J Biol Chem; 2006 Apr; 281(17):11506-14. PubMed ID: 16492675
[TBL] [Abstract][Full Text] [Related]
8. Interaction of transforming growth factor-beta receptor I with farnesyl-protein transferase-alpha in yeast and mammalian cells.
Ventura F; Liu F; Doody J; Massagué J
J Biol Chem; 1996 Jun; 271(24):13931-4. PubMed ID: 8663177
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of Ser165 in TGF-beta type I receptor modulates TGF-beta1-induced cellular responses.
Souchelnytskyi S; ten Dijke P; Miyazono K; Heldin CH
EMBO J; 1996 Nov; 15(22):6231-40. PubMed ID: 8947046
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of mouse Elf3 C-terminal DNA-binding domain in complex with type II TGF-beta receptor promoter DNA.
Agarkar VB; Babayeva ND; Wilder PJ; Rizzino A; Tahirov TH
J Mol Biol; 2010 Mar; 397(1):278-89. PubMed ID: 20079749
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors.
Chen CL; Huang SS; Huang JS
J Cell Physiol; 2008 Apr; 215(1):223-33. PubMed ID: 17972267
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma.
Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K
Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
15. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor receptor type II (ec-TβR II) behaves as a halophile.
Saini K; Khan MA; Chakrapani S; Deep S
Int J Biol Macromol; 2015 Jan; 72():1104-10. PubMed ID: 25316422
[TBL] [Abstract][Full Text] [Related]
17. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.
Rotzer D; Roth M; Lutz M; Lindemann D; Sebald W; Knaus P
EMBO J; 2001 Feb; 20(3):480-90. PubMed ID: 11157754
[TBL] [Abstract][Full Text] [Related]
18. Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling.
Datta PK; Chytil A; Gorska AE; Moses HL
J Biol Chem; 1998 Dec; 273(52):34671-4. PubMed ID: 9856985
[TBL] [Abstract][Full Text] [Related]
19. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW
J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632
[TBL] [Abstract][Full Text] [Related]
20. Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors.
Gebken J; Feydt A; Brinckmann J; Notbohm H; Müller PK; Bätge B
J Endocrinol; 1999 Jun; 161(3):503-10. PubMed ID: 10334821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
